Cancer and venous thromboembolism
P Prandoni, A Falanga, A Piccioli - The lancet oncology, 2005 - thelancet.com
Venous thromboembolism occurs commonly in patients with cancer. The pathogenetic
mechanisms of thrombosis involve a complex interaction between tumour cells, the …
mechanisms of thrombosis involve a complex interaction between tumour cells, the …
Heparin in tumor progression and metastatic dissemination
A Falanga, M Marchetti - Seminars in thrombosis and …, 2007 - thieme-connect.com
Malignancy is an acquired thrombophilic condition that significantly increases the risk of
thrombosis. Both venous and arterial thromboembolisms are recognized complications in …
thrombosis. Both venous and arterial thromboembolisms are recognized complications in …
Effect of anticoagulant drugs in cancer
A Falanga, A Piccioli - Current opinion in pulmonary medicine, 2005 - journals.lww.com
An antineoplastic effect of anticoagulant agents has often been suggested. Heparin and
vitamin K antagonists have both been tested in this context. Heparin has been more …
vitamin K antagonists have both been tested in this context. Heparin has been more …
[PDF][PDF] Kanker en (anti) stolling
CPW Klerk - Ned Tijdschr Hematol, 2006 - ariez.nl
Op 18 januari 2005 promoveerde drs. CPW Klerk aan de Universiteit van Amsterdam op het
promotieonderzoek getiteld 'Cancer, coagulation and antithrombotics' onder begeleiding …
promotieonderzoek getiteld 'Cancer, coagulation and antithrombotics' onder begeleiding …
Venous Thromboembolism and Malignant Diseases
P Prandoni, A Piccioli… - Venous and Lymphatic …, 2006 - api.taylorfrancis.com
Thromboembolism is a well-recognized complication of malignant disease.
Clinicalmanifestations vary from venous thromboembolism (VTE) to disseminated …
Clinicalmanifestations vary from venous thromboembolism (VTE) to disseminated …